| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444885 | European Journal of Cancer | 2013 | 14 Pages |
Abstract
The available evidence indicates that for some women with early invasive breast cancer SLND appears to be a justifiable alternative to ALND. Surgeons need to discuss advantages and disadvantages of both approaches with their patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anna Glechner, Achim Wöckel, Gerald Gartlehner, Kylie Thaler, Michaela Strobelberger, Ursula Griebler, Rolf Kreienberg,